Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Combination With CRT for LA-SCCHN
- Status
- COMPLETED
- Phase
- PHASE1
Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC
- Status
- COMPLETED
- Phase
- PHASE1
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Status
- RECRUITING
- Phase
- PHASE3
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)
- Status
- COMPLETED
- Phase
- PHASE3
Avelumab in First-line NSCLC (JAVELIN Lung 100)
- Status
- COMPLETED
- Phase
- PHASE3
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- NA